In a solo episode of the podcast, Nico Misleh dives into one of the most important and often misunderstood principles of hormone replacement therapy. He frames HRT as a field that combines science with nuance, humility, and a bit of art. The core message is straightforward but profound: hormones given from the outside in do not behave the same as hormones produced from the inside out. Clinicians who understand this distinction make better treatment decisions and achieve better outcomes for patients.
The Core Principle Explained
Exogenous hormone replacement therapy is not a one-to-one process with endogenous hormone production and processing. Exogenous hormones are medicines delivered as pills, injections, creams, or gels. Endogenous hormones are those made inside the body by the gonads, adrenal glands, and other tissues. They may be chemically identical, but their origin, delivery, metabolism, and downstream effects can be very different. Recognizing that difference matters clinically.
Why The Difference Matters: The Testosterone Example
One of the clearest examples Nico gives involves testosterone replacement in men. Healthy testicular production is often quoted in endocrinology as roughly 7 to 10 milligrams per day, which adds up to around 70 milligrams per week. Some providers presume that replacing 70 to 80 milligrams per week should mimic physiology. In practice, many patients do not respond to that approach.
Nico explains that typical symptom resolution for many men often requires higher total weekly doses, commonly in the 150 to 200 milligrams per week range, divided for steadier levels. When a clinician gives a dose that is too small, the pituitary senses the exogenous testosterone and suppresses luteinizing hormone and follicle-stimulating hormone. The result can be decreased intra-testicular hormone production, a drop in sperm production and other testicular steroids, and persistent symptoms despite treatment. He calls this outcome close to a chemical castration when dosing is inadequate.
That suppression is not evidence that the therapy is failing in every way. Randomized trials and large observational studies show that appropriately dosed testosterone therapy improves quality of life and lowers all-cause mortality in many patient populations. The point is to appreciate the physiology and use dosing strategies that restore function without unintended consequences.
Lab Numbers Guide, Symptoms Decide
Nico cautions against letting lab values and reference ranges be the sole decision makers. Hormone care cannot be reduced to a one-size-fits-all algorithm. He compares HRT to insulin management, where, even with the same starting blood glucose, two people may need different insulin doses because of differences in size, stress, insulin sensitivity, and other variables.
Labs matter. They inform decisions. But symptom resolution and improved patient function must be the final benchmark. When a patient still feels unwell, clinicians should reassess dosing, timing, routes of administration, and whether supporting agents like human chorionic gonadotropin make sense.
Human Biology Is Complicated, Not Just Complex
Nico borrows a conceptual distinction: computers are complex systems with deterministic inputs and outputs, while humans are complicated systems with many interacting subsystems and ecological relationships. Hormones do not act in isolation. They interact with receptor sensitivity, intracellular signaling pathways, the microbiome, and environmental variables.
He highlights recent insights about hormone resistance states that mirror insulin resistance. There is growing recognition of androgen resistance and progesterone resistance in some individuals. Hormones can act through classical receptor binding and through intracellular communication that alters gene expression. That variability helps explain why a dose that works well for one patient does not suit another.
To illustrate the systemic nature of biology, Nico points to microbiome science. Transplanting gut communities from a healthy donor can change metabolism, mood, and inflammatory disease in dramatic ways without changing the host genome. Hormone replacement can similarly alter an internal ecosystem and trigger systemic effects that go beyond simply raising a single serum number.
Clinical Humility and Continual Learning
Nico emphasizes humility. HRT is evolving. It requires clinicians to be comfortable with uncertainty and to think deeply about mechanisms and outcomes. He frames the field as rewarding precisely because it invites ongoing learning and creative problem solving.
He shares a personal memory about a teacher who transformed a difficult subject into something meaningful. That story serves as a reminder: with the right guidance, clinicians can move from confusion to competence and develop a practice that is both effective and intellectually satisfying.
Practical Takeaways For Clinicians
- Remember that bioidentical hormones given exogenously will not replicate endogenous physiology exactly.
- Use labs as guides, but prioritize symptom resolution and patient function.
- Avoid low, physiologic-appearing doses that may suppress endogenous production without relieving symptoms.
- Consider adjuncts like hCG when fertility or intra-gonadal hormone production is a concern.
- Recognize receptor sensitivity and resistance as relevant variables.
- Embrace the inherent complexity and commit to lifelong learning in HRT.
FAQ
Q: Will testosterone replacement always suppress fertility?
A: Exogenous testosterone commonly suppresses luteinizing hormone and follicle-stimulating hormone, which can reduce sperm production. If fertility is a goal, consider alternatives or add agents such as hCG that stimulate intra-testicular function.
Q: How should a clinician choose a dose?
A: Start with an informed plan that balances symptom relief and safety. Many patients require higher weekly totals than simple physiologic calculations suggest. Dividing doses for steadier blood levels is often beneficial. Monitor symptoms and labs and adjust accordingly.
Q: Are lab reference ranges the final word?
A: No. Reference ranges are helpful but not definitive. A patient may feel poorly within a so-called normal range. Treat the person, not the number.
Q: Where can clinicians learn more?
A: Nico encourages continuing education, mentorship, and community. For clinicians and interested listeners who want daily insights, practical tips, and continuing discussion from Nico, sign up for his FREE Daily Newsletter!
Hormone replacement therapy is not medicine for the indifferent. It rewards clinicians who bring curiosity, humility, and careful observation. Nico’s encourages all practitioners to think deeply, to respect the difference between exogenous and endogenous hormones, and to put patient function at the center of every decision.
